A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic Cancer
Ko, Andrew H., M.D, Quivey, Jeanne M., M.D, Venook, Alan P., M.D, Bergsland, Emily K., M.D, Dito, Elizabeth, R.N, Schillinger, Brian, R.N, Tempero, Margaret A., M.D
Published in International journal of radiation oncology, biology, physics (01.07.2007)
Published in International journal of radiation oncology, biology, physics (01.07.2007)
Get full text
Journal Article
phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer
Ko, Andrew H, Venook, Alan P, Bergsland, Emily K, Kelley, R. Kate, Korn, W. Michael, Dito, Elizabeth, Schillinger, Brian, Scott, Janet, Hwang, Jimmy, Tempero, Margaret A
Published in Cancer chemotherapy and pharmacology (01.11.2010)
Published in Cancer chemotherapy and pharmacology (01.11.2010)
Get full text
Journal Article
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
Ko, Andrew H., Dito, Elizabeth, Schillinger, Brian, Venook, Alan P., Xu, Zhidong, Bergsland, Emily K., Wong, Derrick, Scott, Janet, Hwang, Jimmy, Tempero, Margaret A.
Published in Investigational new drugs (01.10.2008)
Published in Investigational new drugs (01.10.2008)
Get full text
Journal Article
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
Kavanagh, Brian, Ko, Andrew, Venook, Alan, Margolin, Kim, Zeh, Herbert, Lotze, Michael, Schillinger, Brian, Liu, Weihong, Lu, Ying, Mitsky, Peggie, Schilling, Marta, Bercovici, Nadege, Loudovaris, Maureen, Guillermo, Roy, Lee, Sun Min, Bender, James, Mills, Bonnie, Fong, Lawrence
Published in Journal of immunotherapy (1997) (01.10.2007)
Published in Journal of immunotherapy (1997) (01.10.2007)
Get more information
Journal Article
Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study
Ko, Andrew H., Dito, Elizabeth, Schillinger, Brian, Venook, Alan P., Bergsland, Emily K., Tempero, Margaret A.
Published in Cancer investigation (01.01.2008)
Published in Cancer investigation (01.01.2008)
Get full text
Journal Article